secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001213900-23-055873
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phoenix Biotech SPAC extends business combination deadline to Jan 2024 after shareholder vote; ~523k shares redeemed
--------------------------------------------------------------------------------

- Stockholders approved charter and trust amendments allowing up to six monthly extensions through January 8, 2024.
- Holders of 523,341 Class A shares exercised redemption rights; paid $10.74 per share, totaling ~$5.6M.
- Sponsor deposited $37,052 into trust for first extension; trust balance now ~$8.3M.
- 6,246,207 Class A shares outstanding post-redemption, with 4,596,250 from converted Sponsor-held Class B shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023055873/0001213900-23-055873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023055873/ea181547-8k425_phoenix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-055873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer